| Financier | Commitments |
|---|---|
| International Bank for Reconstruction and Development | 20.00 |
El Salvador COVID-19 Emergency Response Project
Abstract*
The purpose of the COVID-19 Emergency Response Project in El Salvador is to respond to and mitigate the threat posed by COVID-19 (Coronavirus) and strengthen the national system for public health preparedness. This project consists of two components. Component one consists of emergency COVID-19 response to prevention, detection and treatment. There are two subcomponents: Subcomponent 1.1 is the provision of medicines, medical supplies and equipment... Show More
Development Objective
To respond to and mitigate the threat posed by COVID-19 and strengthen the national system for public health preparedness in El Salvador.
Key Details
Project Details
P173872
Closed
Gianluca Cafagna , Daniela Romero
Republic of El Salvador
April 11, 2020
(as of board presentation)
April 17, 2020
August 26, 2020
US$ 70.00 million
Ministry of Health
2020
US$ 20.00 million
N/A
February 14, 2024
July 20, 2024
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | 20.00 |
| IDA Commitment | N/A |
| IBRD + IDA Commitment | 20.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 70.00 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| Sep 23, 2021 | IBRD-92290 | Fee Charges | 125,000.00 |
| Nov 15, 2020 | IBRD-91000 | Int Charges | 158.63 |
| May 15, 2021 | IBRD-91000 | Int Charges | 289.09 |
| Aug 26, 2020 | IBRD-91000 | Loan Disb | 50,000.00 |
| Aug 26, 2020 | IBRD-91000 | Fee Charges | 50,000.00 |
| Jan 6, 2022 | IBRD-92290 | Loan Disb | -20,625,000.00 |
| Jan 6, 2022 | IBRD-92290 | Loan Disb | 20,625,000.00 |
| Jan 6, 2022 | IBRD-91000 | Loan Disb | -4,550,000.00 |
| Jan 6, 2022 | IBRD-91000 | Loan Disb | 4,550,000.00 |
| Feb 17, 2022 | IBRD-92290 | Loan Disb | -10,000,000.00 |
| Feb 17, 2022 | IBRD-92290 | Loan Disb | 10,000,000.00 |
| May 15, 2022 | IBRD-91000 | Int Charges | 20,052.66 |
| Apr 15, 2022 | IBRD-92290 | Int Charges | 71.04 |
| Apr 15, 2022 | IBRD-92290 | Int Charges | 8,522.02 |
| Apr 15, 2022 | IBRD-92290 | Int Charges | 154,275.00 |
| May 15, 2022 | IBRD-91000 | Int Charges | 20,052.66 |
| May 2, 2022 | IBRD-91000 | Loan Disb | 1,499,250.00 |
| May 4, 2022 | IBRD-91000 | Loan Disb | 115,711.88 |
| May 15, 2022 | IBRD-91000 | Int Charges | 2,726.01 |
| May 15, 2022 | IBRD-91000 | Int Charges | 27,392.46 |
| Nov 15, 2021 | IBRD-92290 | Loan Disb | 500,000.00 |
| Nov 15, 2021 | IBRD-91000 | Int Charges | 1,795.11 |
| Nov 15, 2022 | IBRD-91000 | Int Charges | 142.21 |
| Oct 14, 2022 | IBRD-94290 | Loan Disb | -14,738,766.00 |
| Oct 14, 2022 | IBRD-94290 | Loan Disb | 14,738,766.00 |
| Sep 28, 2022 | IBRD-91000 | Loan Disb | -14,614,962.00 |
| Sep 28, 2022 | IBRD-91000 | Loan Disb | 14,614,962.00 |
| Sep 28, 2022 | IBRD-92290 | Loan Disb | -9,500,000.00 |
| Sep 28, 2022 | IBRD-92290 | Loan Disb | 9,500,000.00 |
| May 15, 2023 | IBRD-94290 | Int Charges | 180,336.61 |
| May 15, 2023 | IBRD-94290 | Int Charges | 566,086.00 |
| May 15, 2023 | IBRD-91000 | Int Charges | 59,748.46 |
| May 15, 2023 | IBRD-91000 | Int Charges | 11,737.32 |
| May 15, 2023 | IBRD-94290 | Int Charges | 24,475.04 |
| May 15, 2023 | IBRD-94290 | Int Charges | 64,195.52 |
| May 15, 2023 | IBRD-91000 | Int Charges | 1,035.20 |
| May 15, 2023 | IBRD-91000 | Int Charges | 24,717.24 |
| May 15, 2023 | IBRD-91000 | Int Charges | 1,035.20 |
| May 15, 2023 | IBRD-91000 | Int Charges | 66,570.29 |
| May 15, 2023 | IBRD-91000 | Int Charges | 329,193.88 |
| May 15, 2023 | IBRD-94290 | Int Charges | 673,225.06 |
| May 15, 2023 | IBRD-94290 | Int Charges | 331,241.50 |
| Apr 15, 2023 | IBRD-92290 | Int Charges | 12,242.31 |
| Apr 15, 2023 | IBRD-92290 | Int Charges | 283,616.66 |
| Apr 15, 2023 | IBRD-92290 | Int Charges | 4,058.17 |
| Apr 15, 2023 | IBRD-92290 | Int Charges | 22,116.53 |
| Apr 15, 2023 | IBRD-92290 | Int Charges | 12,242.31 |
| Apr 15, 2024 | IBRD-92290 | Int Charges | 231,800.00 |
| Oct 15, 2023 | IBRD-92290 | Int Charges | 12,377.58 |
| Oct 15, 2023 | IBRD-92290 | Int Charges | 12,377.58 |
| Oct 15, 2023 | IBRD-92290 | Int Charges | 285,175.00 |
| Oct 15, 2023 | IBRD-92290 | Int Charges | 156,058.31 |
| Oct 15, 2023 | IBRD-92290 | Int Charges | 204,934.92 |
| Nov 15, 2023 | IBRD-94290 | Int Charges | 4,589.74 |
| Nov 15, 2023 | IBRD-94290 | Int Charges | 249,864.05 |
| Nov 15, 2023 | IBRD-94290 | Int Charges | 587,712.70 |
| Nov 15, 2023 | IBRD-94290 | Int Charges | 698,944.90 |
| Nov 15, 2023 | IBRD-94290 | Int Charges | 342,758.20 |
| Nov 15, 2023 | IBRD-91000 | Int Charges | 67,673.66 |
| Nov 15, 2023 | IBRD-91000 | Int Charges | 340,626.03 |
| Nov 15, 2023 | IBRD-91000 | Int Charges | 1,052.36 |
| Apr 16, 2021 | IBRD-92290 | Loan Commitment | 50,000,000.00 |
| Apr 17, 2020 | IBRD-91000 | Loan Commitment | 20,000,000.00 |
| Jun 15, 2022 | IBRD-94290 | Loan Commitment | 100,000,000.00 |
| Apr 26, 2024 | IBRD-94290 | Loan Disb | -19,704,634.00 |
| Apr 26, 2024 | IBRD-94290 | Loan Disb | 19,704,634.00 |
| May 15, 2024 | IBRD-91000 | Int Charges | 491.26 |
| May 15, 2024 | IBRD-91000 | Int Charges | 1,850.64 |
| May 15, 2024 | IBRD-94290 | Int Charges | 745,359.20 |
| May 15, 2024 | IBRD-94290 | Int Charges | 354,681.12 |
| May 15, 2024 | IBRD-91000 | Int Charges | 491.26 |
| May 15, 2024 | IBRD-94290 | Int Charges | 1,572.84 |
| May 15, 2024 | IBRD-94290 | Int Charges | 9,776.99 |
| May 15, 2024 | IBRD-94290 | Int Charges | 260,714.27 |
| May 15, 2024 | IBRD-94290 | Int Charges | 626,740.50 |
| May 15, 2024 | IBRD-94290 | Int Charges | 6,705.25 |
| May 15, 2024 | IBRD-91000 | Int Charges | 359,089.62 |
| May 15, 2024 | IBRD-91000 | Int Charges | 66,938.08 |
| May 15, 2024 | IBRD-91000 | Int Charges | 9,913.33 |
| Feb 12, 2024 | IBRD-92290 | Loan Disb | 9,875,000.00 |
| Feb 9, 2024 | IBRD-91000 | Loan Disb | 835,038.10 |
| Feb 21, 2024 | IBRD-91000 | Loan Disb | 835,038.10 |
| Feb 21, 2024 | IBRD-91000 | Loan Disb | -835,038.10 |
| Feb 21, 2024 | IBRD-92290 | Loan Disb | -9,875,000.00 |
| Feb 21, 2024 | IBRD-92290 | Loan Disb | 9,875,000.00 |
| Apr 15, 2024 | IBRD-92290 | Int Charges | 8,108.68 |
| Apr 15, 2024 | IBRD-94290 | Loan Disb | 11,727,903.00 |
| Apr 15, 2024 | IBRD-92290 | Int Charges | 16,036.82 |
| Apr 15, 2024 | IBRD-92290 | Int Charges | 285,175.00 |
| Apr 15, 2024 | IBRD-92290 | Int Charges | 156,058.33 |
| Aug 10, 2021 | IBRD-91000 | Loan Disb | 500,000.00 |
| Nov 15, 2021 | IBRD-91000 | Int Charges | 13,878.76 |
| Sep 23, 2021 | IBRD-92290 | Loan Disb | 125,000.00 |
| Dec 23, 2021 | IBRD-91000 | Loan Disb | 4,000,000.00 |
| Nov 15, 2022 | IBRD-94290 | Int Charges | 61,842.14 |
| Nov 15, 2022 | IBRD-94290 | Int Charges | 271,847.06 |
| Nov 15, 2022 | IBRD-94290 | Int Charges | 323,297.62 |
| Oct 15, 2022 | IBRD-92290 | Int Charges | 34,577.77 |
| Oct 15, 2022 | IBRD-92290 | Int Charges | 285,175.00 |
| Oct 15, 2022 | IBRD-92290 | Int Charges | 155,205.55 |
| Nov 15, 2022 | IBRD-91000 | Int Charges | 67,673.66 |
| Dec 27, 2021 | IBRD-92290 | Loan Disb | 20,000,000.00 |
| Aug 29, 2022 | IBRD-94290 | Loan Disb | -29,944,600.00 |
| Aug 29, 2022 | IBRD-94290 | Loan Disb | 29,944,600.00 |
| Aug 29, 2022 | IBRD-94290 | Loan Disb | -35,612,000.00 |
| Aug 29, 2022 | IBRD-94290 | Loan Disb | 35,612,000.00 |
| Aug 1, 2022 | IBRD-94290 | Loan Disb | 250,000.00 |
| Aug 1, 2022 | IBRD-94290 | Fee Charges | 250,000.00 |
| Feb 8, 2022 | IBRD-92290 | Loan Disb | 10,000,000.00 |
| Aug 18, 2022 | IBRD-94290 | Loan Disb | 5,000,000.00 |
| Aug 22, 2022 | IBRD-94290 | Loan Disb | 30,612,000.00 |
| Aug 17, 2022 | IBRD-94290 | Loan Disb | 29,694,600.00 |
| Apr 15, 2023 | IBRD-92290 | Int Charges | 155,205.55 |
| Apr 15, 2023 | IBRD-92290 | Int Charges | 212,282.78 |
| Nov 15, 2022 | IBRD-94290 | Int Charges | 271,847.06 |
| Nov 15, 2022 | IBRD-94290 | Int Charges | 323,297.62 |
| Nov 15, 2022 | IBRD-94290 | Int Charges | 61,842.14 |
| Dec 12, 2022 | IBRD-94290 | Loan Disb | 7,976,730.50 |
| Nov 15, 2022 | IBRD-94290 | Int Charges | -61,842.14 |
| Nov 15, 2022 | IBRD-94290 | Int Charges | -271,847.06 |
| Nov 15, 2022 | IBRD-94290 | Int Charges | -323,297.62 |
| Nov 15, 2022 | IBRD-91000 | Int Charges | 526.82 |
| Nov 15, 2022 | IBRD-91000 | Int Charges | 11,737.32 |
| Nov 15, 2022 | IBRD-91000 | Int Charges | 42,656.07 |
| Sep 30, 2022 | IBRD-94290 | Loan Disb | 14,738,766.00 |
| Oct 15, 2022 | IBRD-92290 | Int Charges | 14,883.34 |
| Sep 12, 2022 | IBRD-91000 | Loan Disb | 13,000,000.00 |
| Sep 12, 2022 | IBRD-92290 | Loan Disb | 9,500,000.00 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Highly Satisfactory | 2024-10-17 |
| Procurement | Satisfactory | 2024-10-17 |
| Project Management | Satisfactory | 2024-10-17 |
| Overall Implementation Progress (IP) | Satisfactory | 2024-10-17 |
| Financial Management | Satisfactory | 2024-10-17 |
| Monitoring and Evaluation | Satisfactory | 2024-10-17 |
| Progress towards achievement of PDO | Highly Satisfactory | 2024-10-17 |
| Procurement | Satisfactory | 2024-10-17 |
| Project Management | Satisfactory | 2024-10-17 |
| Financial Management | Satisfactory | 2024-10-17 |
| Monitoring and Evaluation | Satisfactory | 2024-10-17 |
| Overall Implementation Progress (IP) | Satisfactory | 2024-10-17 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Confirmed cases of COVID-19 reported and investigated based on national guidelines. Value 0.00 100.00 70.00 Date April 2, 2020 December 18, 2023 June 30, 2024 Comment ICU beds in prioritized ICUs that are fully equipped and operational in the COVID-19 network health care facilities. Value 21.00 79.00 70.00 Date April 2, 2020 December 18, 2023 June 30, 2024 Comment Population vaccinated, based on the targets defined by El Salvador's National COVID-19 Vaccination Plan (total and disaggregated bygender) Value 0.00 85.00 80.00 Date January 29, 2021 December 18, 2023 June 30, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Health network units with personal protective equipment and infection control products and supplies. Value 0.00 100.00 70.00 Date April 2, 2020 March 9, 2023 June 30, 2024 Comment COVID-19 communication activities which promote the prevention of illness, the acceptance of the vaccine and the role of the healthcare workers (male and female) Value 0.00 8390288.00 6314000.00 Date April 2, 2020 December 18, 2023 June 30, 2024 Comment User Satisfaction Survey applied and reported Value No No Yes Date January 29, 2021 March 9, 2023 June 30, 2024 Comment Health staff trained in provision of COVID-19 vaccination per MoH-approved protocols differentiated by gender. Value 0.00 3520.00 1300.00 Date January 29, 2021 March 9, 2023 June 30, 2024 Comment Vaccination sites targeted by the Project with energy efficient equipment Value 0.00 100.00 100.00 Date January 29, 2021 March 9, 2023 June 30, 2024 Comment Increased share of female health workers that report they are better equipped to handle mental and emotional stress during the pandemic. Value 0.00 82.27 80.00 Date February 26, 2021 December 18, 2023 June 30, 2024 Comment Number of hospitals strengthened with diagnostic imaging equipment Value 0.00 11.00 12.00 Date April 2, 2020 December 5, 2023 June 30, 2024 Comment